Virica Logo

Virica Biotech Raises Series A Financing & Expands Operations to Support Clients’ Manufacturing of Viral Medicines

2022-02-04T08:57:31-05:00

OTTAWA – October 4, 2021 – Virica Biotech Inc., a leading life science developer of solutions for scaling of viral medicines, announced today the first closing of its Series A financing. The round, led by Dynamk Capital, is expected to close with additional investors by the end of Q4-2021. The investment strengthens Virica’s already impressive growth [...]

Virica Biotech Raises Series A Financing & Expands Operations to Support Clients’ Manufacturing of Viral Medicines2022-02-04T08:57:31-05:00

Virica Biotech: Enabling Vaccine Development to Fight Against COVID-19

2022-02-04T08:57:13-05:00

March 14, 2020—As the world deals with COVID-19, now officially deemed a pandemic, many groups are racing against the clock to develop vaccines against the novel coronavirus. The development and manufacturing of effective vaccines is a laborious and challenging task for a variety of reasons. In the pandemic situation that we and our loved [...]

Virica Biotech: Enabling Vaccine Development to Fight Against COVID-192022-02-04T08:57:13-05:00
Go to Top